STACKDSTACKDResearch
Sign up

Compound library

Peptides

Deep profiles for diligence, not product pages. Filter by goal or open any profile for mechanism, evidence, and citations.

45 compounds catalogued

Filter by goal

Retatrutide

Stronger clinical signal

An investigational triple agonist (GLP-1, GIP, and glucagon receptors) studied for obesity and metabolic disease. Currently the highest-profile name in the space, widely framed as the next-generation successor to tirzepatide, with heavy search interest among fitness audiences.

Fat loss · Metabolic

Semaglutide

Stronger clinical signal

A GLP-1 receptor agonist (marketed as Ozempic, Wegovy, and Rybelsus) with robust clinical evidence for glycemic control and weight management. The molecule that mainstreamed this category and a reference point for understanding incretin-based approaches discussed in fitness communities.

Fat loss · Metabolic

Tirzepatide

Stronger clinical signal

A dual GIP/GLP-1 receptor agonist (marketed as Mounjaro and Zepbound) with extensive clinical data in type 2 diabetes and obesity. Frequently compared head-to-head with semaglutide in conversations about metabolic peptides and body recomposition.

Fat loss · Metabolic

BPC-157

Emerging

A synthetic peptide fragment derived from a gastric protein, widely discussed for soft-tissue recovery. Human evidence remains limited relative to its online popularity.

Recovery · Skin / repair · Gut health

Cagrilintide

Stronger clinical signal

A long-acting amylin-receptor analogue from Novo Nordisk, studied alone and paired with semaglutide (as "CagriSema") for weight management and type 2 diabetes. Currently one of the most-discussed "next after tirzepatide/retatrutide" names in metabolic-peptide circles.

Metabolic · Fat loss

Survodutide

Stronger clinical signal

A Boehringer Ingelheim glucagon-receptor/GLP-1-receptor dual agonist in late-stage development for obesity and MASH (fatty liver disease). Part of the current wave of multi-receptor peptides competing with tirzepatide and retatrutide for the metabolic-peptide spotlight.

Metabolic · Fat loss

TB-500

Emerging

A synthetic peptide associated with thymosin beta-4 research, commonly discussed alongside soft-tissue recovery and mobility. Often paired conversationally with BPC-157.

Recovery · Skin / repair

CJC-1295

Limited human data

A growth hormone-releasing hormone (GHRH) analogue discussed for GH-axis support. Often mentioned with ipamorelin in fitness forums as a commonly discussed pairing.

Muscle / GH axis · Recovery · Sleep / recovery adjunct

Ipamorelin

Limited human data

A selective growth hormone secretagogue (ghrelin-receptor agonist) discussed for GH pulses with a relatively favorable selectivity profile in older literature.

Muscle / GH axis · Recovery · Sleep / recovery adjunct

Sermorelin

Limited human data

A 29-amino-acid fragment of growth hormone-releasing hormone (GHRH) that stimulates the pituitary to release the body's own growth hormone. Once an FDA-approved drug for pediatric growth hormone deficiency, it is now mostly used off-label and compounded for adult anti-aging and GH-optimization protocols.

Muscle / GH axis · Longevity / aging

Tesamorelin

Stronger clinical signal

A synthetic GHRH analogue with an approved indication for reducing excess abdominal fat in specific HIV-associated lipodystrophy contexts, often referenced when discussing visceral fat and GH axis research.

Fat loss · Muscle / GH axis · Metabolic

Semax

Limited human data

A synthetic heptapeptide analogue of ACTH(4-10), registered as a prescription drug in Russia for ischemic stroke and optic nerve conditions. One of the most frequently discussed "nootropic peptides" in biohacking communities, alongside Selank.

Cognitive / nootropic · Neuroprotection

Selank

Limited human data

A synthetic heptapeptide anxiolytic developed alongside Semax at Russia's Institute of Molecular Genetics, studied for generalized anxiety disorder and neurasthenia. Frequently paired with Semax in nootropic-peptide discussions.

Cognitive / nootropic · Mood / anxiety

MOTS-c

Emerging

A mitochondria-derived peptide researched for metabolic regulation and exercise-related stress responses. Still early relative to incretin drugs, but frequently searched in biohacking circles.

Metabolic · Fat loss · Recovery · Longevity / aging

Thymosin Alpha-1

Stronger clinical signal

A 28-amino-acid immunomodulatory peptide, marketed in dozens of countries as Zadaxin/thymalfasin for chronic viral hepatitis and as an immune-response adjunct in cancer and infection. One of the few peptides in this space with genuine international drug-approval history.

Immune support · Longevity / aging

Bremelanotide

Stronger clinical signal

A melanocortin-receptor agonist derived from Melanotan II research, FDA-approved as Vyleesi for hypoactive sexual desire disorder (HSDD) in premenopausal women. Notable as one of the only peptides in this category with a formal drug approval.

Sexual health

GHK-Cu

Limited human data

A copper-binding tripeptide studied in skin biology and remodeling. Appears in topical cosmetic research and in online discussions of recovery and tissue quality.

Skin / repair · Recovery

Hexarelin

Limited human data

A synthetic hexapeptide growth hormone secretagogue that activates the ghrelin receptor, producing one of the strongest GH releases of any peptide in its class. Distinct among GH secretagogues for a separate, GH-independent cardioprotective effect documented in animal models.

Muscle / GH axis · Recovery

GHRP-2

Limited human data

A synthetic hexapeptide ghrelin receptor agonist that stimulates growth hormone release. Notable for being the one compound in this family with a real regulatory approval, marketed in Japan as a diagnostic agent for GH deficiency under the name pralmorelin.

Muscle / GH axis · Recovery

Noopept

Limited human data

A synthetic dipeptide developed as a piracetam analogue, sold as a prescription nootropic in Russia for cognitive impairment following stroke and traumatic brain injury. A recurring name in international nootropic-stacking discussions despite thin Western trial data.

Cognitive / nootropic

GHRP-6

Limited human data

The original growth hormone-releasing hexapeptide, discovered in 1984 and the founding compound of the entire GHRP family, including GHRP-2 and hexarelin. Known for producing the strongest appetite stimulation of the group alongside its GH-releasing effect.

Muscle / GH axis · Recovery

Melanotan II

Limited human data

A non-selective melanocortin-receptor agonist originally studied for skin tanning and erectile dysfunction, whose sexual-desire side effects led directly to the development of the FDA-approved drug bremelanotide (PT-141). Widely sold gray-market for tanning despite no approval for that use.

Sexual health

Gonadorelin

Limited human data

The synthetic form of the body's own gonadotropin-releasing hormone, historically FDA-approved for pituitary function testing and pulsatile ovulation induction. Now widely discussed off-label alongside testosterone replacement therapy to help preserve natural testicular function and fertility.

Sexual health

Cerebrolysin

Limited human data

A mixture of low-molecular-weight peptides and amino acids derived from purified porcine brain proteins, approved in several countries for stroke and traumatic brain injury recovery. Distinct from single-sequence research peptides: it's a multi-component biological preparation.

Cognitive / nootropic · Neuroprotection

IGF-1 LR3

Emerging

An engineered analog of insulin-like growth factor 1 with reduced binding to its natural binding proteins, giving it a longer half-life and greater potency than native IGF-1. Studied in animals as a research tool for IGF-1 receptor biology, not developed or tested as a human therapeutic.

Muscle / GH axis

Larazotide Acetate

Limited human data

A first-in-class oral peptide designed to keep intestinal tight junctions closed, studied as an adjunct therapy for celiac disease alongside a gluten-free diet. One of the more rigorously trialed gut-health peptides, with multiple completed phase 2 RCTs.

Gut health

SS-31 (Elamipretide)

Stronger clinical signal

A mitochondria-targeted peptide that stabilizes cardiolipin in the inner mitochondrial membrane, supporting energy production and reducing oxidative stress. FDA-approved as elamipretide for Barth syndrome, a rare genetic mitochondrial disease, and one of the few peptides in this category with an actual regulatory approval.

Longevity / aging · Recovery

LL-37

Limited human data

The only human cathelicidin antimicrobial peptide, naturally released at wound margins during healing. Studied as a synthetic topical treatment for hard-to-heal chronic wounds, giving it more human RCT support than most "recovery peptide" research chemicals.

Immune support · Skin / repair

Melanotan I (Afamelanotide)

Stronger clinical signal

A linear analog of alpha-MSH that selectively activates the MC1R melanocortin receptor to stimulate melanin production. FDA-approved under the name afamelanotide (Scenesse) for a rare light-sensitivity disorder, though the compound sold in research and tanning circles as "Melanotan 1" is not the same regulated product.

Skin / repair

Kisspeptin-54

Limited human data

A naturally occurring neuropeptide that is the master regulator of the reproductive hormone axis, now in early clinical development as a fertility and psychosexual therapeutic. Distinct from the melanocortin-based sexual-health peptides: it works directly on the reproductive hormone cascade.

Sexual health

A naturally occurring protein that neutralizes myostatin and related growth-inhibiting signals, allowing muscle to grow beyond its normal ceiling. The systemically circulating isoform used in early-phase gene therapy trials for muscular dystrophy, now also sold as a standalone research peptide with no human data in that injectable form.

Muscle / GH axis · Recovery

AOD-9604

Limited human data

A fragment of the C-terminal region of human growth hormone historically investigated for fat metabolism without full GH receptor agonism claims.

Fat loss

A splice variant of IGF-1 that muscle tissue produces locally in response to mechanical stretch, stimulation, or injury. Studied mainly in animal and cell models of muscle repair and regeneration; sold as a synthetic research peptide despite very limited direct human data.

Muscle / GH axis · Recovery

Humanin

Emerging

A 24-amino-acid peptide encoded within mitochondrial DNA itself, part of a growing family of "mitochondrial-derived peptides" (alongside MOTS-c) studied in aging and cellular-stress biology.

Longevity / aging

PEG-MGF

Emerging

A polyethylene glycol-modified version of MGF designed to extend the parent peptide's minutes-long half-life to several days. A research-chemical product built on real underlying biology, but with essentially no dedicated studies of its own, pegylated form.

Muscle / GH axis · Recovery

A nonapeptide isolated from rabbit cerebral venous blood in the 1970s and named for its apparent sleep-promoting effect in early animal work. One of the oldest "sleep peptides" discussed online, though its own reviewers call its biological role "a still unresolved riddle."

Sleep / recovery adjunct

5-Amino-1MQ

Emerging

A small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme involved in fat-cell metabolism and NAD+ regulation. Reduced fat mass in diet-induced-obese mice without affecting food intake, but has never been tested in a published human clinical trial.

Fat loss · Metabolic · Longevity / aging

KPV

Emerging

The smallest active fragment of alpha-MSH (just three amino acids), studied almost entirely in mouse models of inflammatory bowel disease as an anti-inflammatory candidate. A clear example of a peptide with real preclinical mechanism data but essentially no human trials.

Gut health · Skin / repair

ARA-290 (Cibinetide)

Limited human data

An 11-amino-acid peptide engineered from a non-erythropoietic region of erythropoietin, designed to activate tissue-repair signaling without stimulating red blood cell production. Studied in phase 2 human trials for small-fiber neuropathy, one of the more clinically tested "tissue protective" peptides.

Recovery · Neuroprotection

Epitalon

Emerging

A synthetic tetrapeptide associated with pineal peptide research and aging biology conversations. Evidence is largely historical/preclinical with limited modern RCT coverage.

Longevity / aging · Sleep / recovery adjunct · Recovery

Thymalin

Emerging

A complex of polypeptides extracted from calf thymus tissue, used clinically in Russia since the 1970s as an immune-modulating and geroprotective agent. Backed mainly by Russian-language research from a single research institute, without independent replication in Western trials.

Immune support · Longevity / aging

FOXO4-DRI

Emerging

A lab-designed "D-retro-inverso" peptide built to disrupt one specific protein-protein interaction that keeps aged cells alive, making it a purpose-built senolytic rather than a naturally occurring hormone fragment. Widely cited in longevity media as the "reverse aging in mice" peptide.

Longevity / aging

Dihexa

Emerging

A small, orally active molecule derived from angiotensin IV, developed as a potential cognition-enhancing compound by potentiating HGF/c-Met signaling involved in synapse formation. Studied only in animal models; its foundational 2013 paper has since received a formal journal Notice of Concern, adding an important caveat to an already early-stage evidence base.

Cognitive / nootropic · Neuroprotection

Oxytocin

Limited human data

A naturally occurring hormone-peptide best known for its role in childbirth and lactation, popularized far beyond that as the "trust" or "bonding" molecule after a famous 2005 economics experiment. A useful case study in how a single influential paper can outrun its own replication record.

Mood / anxiety

SNAP-8

Emerging

A synthetic cosmetic peptide fragment of the SNAP-25 protein, applied topically to reduce the appearance of expression wrinkles by dampening the neurotransmitter release that drives muscle contraction. An extension of the older, better-known Argireline peptide, marketed as a non-injectable alternative to reduce dynamic wrinkles.

Skin / repair

Evidence labels

  • EmergingMostly preclinical or early signals; human athletic data is thin.
  • Limited human dataSome human pharmacology or small studies; outcomes for fitness use remain limited.
  • Stronger clinical signalSupported by larger clinical trials in defined medical populations.

Anodized by evidence strength: blue = stronger clinical/human data, violet = limited human data or mechanism, steel = emerging/anecdotal, and amber = an in-house STACKD summary.